You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PMF

Showing 26 - 50 of 134
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epigenetic Age on Clinic-biological Presentation and Prognosis

Not yet recruiting
  • Myeloproliferative Neoplasm
  • Assessment of the epigenetic age
  • Bordeaux, France
    CHU de Bordeaux, service Hématologie Biologique
Aug 28, 2023

Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in United States (PU-H71, Ruxolitinib)

Terminated
  • Myelofibrosis
  • +3 more
  • New Haven, Connecticut
  • +9 more
Oct 19, 2020

Myelofibrosis Trial in Worldwide (INC424, BKM120)

Terminated
  • Myelofibrosis
  • Herston, Queensland, Australia
  • +14 more
Dec 16, 2020

Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis

Recruiting
  • Myelofibrosis
  • Hematopoietic Stem Cell Transplant
  • Minneapolis, Minnesota
    Center for International Blood and Marrow Transplant Research
Mar 17, 2022

Ruxolitinib in Patients With Myelofibrosis

Not yet recruiting
  • Myelofibrosis
  • (no location specified)
Feb 28, 2023

Philadelphia Negative Myeloproliferative Tumors Trial

Not yet recruiting
  • Philadelphia Negative Myeloproliferative Neoplasms
    • (no location specified)
    Jun 5, 2022

    Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

    Not yet recruiting
    • Myeloproliferative Neoplasms (MPNs)
    • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
    • (no location specified)
    Mar 24, 2023

    Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in

    Recruiting
    • Primary Myelofibrosis (PMF)
    • +2 more
    • Birmingham, Alabama
    • +155 more
    Aug 12, 2022

    Cardiovascular Diseases Trial in Worldwide

    Recruiting
    • Cardiovascular Diseases
      • Wien, Austria
      • +10 more
      Oct 21, 2022

      Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) Trial

      Completed
      • Primary Myelofibrosis (PMF)
      • +2 more
      • Los Angeles, California
      • +47 more
      Apr 1, 2020

      MPN (Myeloproliferative Tumors) Trial in United States (Ruxolitinib)

      Completed
      Has Results
      • MPN (Myeloproliferative Neoplasms)
      • Birmingham, Alabama
      • +37 more
      Jan 17, 2020

      Myelofibrosis Trial in United States (Ruxolitinib, Thalidomide)

      Active, not recruiting
      • Myelofibrosis
      • Middletown, New Jersey
      • +6 more
      Aug 23, 2022

      Assess the Safety of Fedratinib in Korean Myelofibrosis

      Recruiting
      • Primary Myelofibrosis
      • +2 more
      • Seoul, Korea, Republic of
        Bristol-Myers Squibb YH
      Oct 3, 2023

      Thrombosis in Myeloproliferative Neoplasms

      Completed
      • Myeloproliferative Neoplasm
      • 2 additional tubes of blood
      • Angers, France
      • +23 more
      Aug 17, 2022

      Bone Marrow Fibrosis, Myeloproliferative Tumor Trial in Cleveland (Captopril)

      Not yet recruiting
      • Bone Marrow Fibrosis
      • Myeloproliferative Neoplasm
      • Cleveland, Ohio
        Cleveland Clinic, Case Comprehensive Cancer Center
      Jan 30, 2023

      Polycythemia Vera, Thrombocythemia Trial in Houston (CC-4047, Prednisone)

      Completed
      Has Results
      • Polycythemia Vera
      • Thrombocythemia
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Jun 5, 2019

      Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

      Recruiting
      • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022

      Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary

      Withdrawn
      • Myelofibrosis Transformation in Essential Thrombocythemia
      • +2 more
      • LOXL2 Inhibitor PAT-1251
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 9, 2019

      Myeloproliferative Tumors Trial in Canada, Spain, United States (VAC85135, Ipilimumab)

      Recruiting
      • Myeloproliferative Neoplasms
      • Birmingham, Alabama
      • +16 more
      Jan 27, 2023

      Head and Neck Tumor, Cleft Palate, Cleft Lip Trial in Paris (Questionnaire)

      Completed
      • Head and Neck Neoplasm
      • +2 more
      • Questionnaire
      • Paris, France
        Assistance Publique - Hôpitaux de Paris
      Jan 27, 2022

      Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

      Recruiting
      • Myelofibrosis
      • +3 more
      • Birmingham, Alabama
      • +13 more
      Jan 10, 2023

      Myoma;Uterus, IVF, Surgery Trial (myomectomy or not)

      Not yet recruiting
      • Myoma;Uterus
      • +2 more
      • myomectomy or not
      • (no location specified)
      Jul 6, 2023

      Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

      Completed
      • Primary Myelofibrosis
      • +2 more
      • Phoenix, Arizona
      • +113 more
      Apr 13, 2020

      Myelofibrosis Trial in Worldwide (PIM447, Ruxolitinib, LEE011)

      Completed
      • Myelofibrosis
      • VIC, Melbourne, Australia
      • +8 more
      Feb 7, 2022

      Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

      Completed
      Has Results
      • Primary Myelofibrosis
      • +2 more
      • Scottsdale, Arizona
      • +8 more
      Feb 10, 2022